Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Progress in Rehabilitation Medicine|December 11, 2025
Development and Statistical Validation of a Machine Learning Model for Predicting Functional Outcomes at Discharge after Bipolar Hip ArthroplastyTakehiro Kaneoka, Tomohiro Kawazoe, Kazuhiro Yamazaki, et al.
Internal Medicine (Tokyo, Japan)|January 18, 2021
Rapidly Progressive Kidney Failure Associated with Perirenal Capsular Lesion Due to IgG4-Related DiseaseNobuhide Endo, Hitomi Shimizu, Tomoki Tanaka, et al.
Internal Medicine (Tokyo, Japan)|December 24, 2019
Long-term Successful Treatment of Rituximab for Steroid-resistant Minimal Change Nephrotic Syndrome and Idiopathic Thrombocytopenic PurpuraMana Nishikawa, Noriaki Shimada, Tomohiro Kawazoe, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|November 20, 2025
Frequency of Home Therapy Among Patients Who Underwent Kidney Transplantation Followed by Maintenance DialysisAkihito Tanaka, Kazuhiro Furuhashi, Kumiko Fujieda, et al.
BMC Nephrology|December 2, 2024
Association between alpha blocker use and the risk of fractures in patients with chronic kidney disease: a cohort studyKeisuke Sunohara, Chikao Onogi, Akihito Tanaka, et al.
Stem Cell Research|July 9, 2025
Establishment of the NUMNi001-A human iPSC line from peripheral blood mononuclear cells of a healthy male donorAkihito Tanaka, Kazuhiro Furuhashi, Jun Matsumoto, et al.
Scientific Reports|December 3, 2024
Urinary presepsin is a novel biomarker capable of directly assessing monocyte/macrophage infiltration in kidney diseasesShunsuke Niwa, Akihito Tanaka, Kazuhiro Furuhashi, et al.
Clinical and Experimental Nephrology|April 5, 2025
Urinary presepsin can efficiently detect T-cell-mediated rejection in patients who have undergone kidney transplantationTomohiro Kawazoe, Akihito Tanaka, Kazuhiro Furuhashi, et al.
Stem Cell Research|March 18, 2026
Generation of a human-induced pluripotent stem cell line (NUMNi003-A) from a patient with autosomal dominant polycystic kidney disease harboring a PKD1 gene variantAkihito Tanaka, Kazuhiro Furuhashi, Asuka Horinouchi, et al.
Stem Cells and Development|June 18, 2026
Evaluation of Puromycin-Induced Podocyte Injury and Protective Effects of Voclosporin Using Induced Pluripotent Stem Cells from a Patient with Nephrotic Syndrome Harboring an INF2 VariantAkihito Tanaka, Kazuhiro Furuhashi, Saki Sakamoto, et al.
Pageof 2